Brand pharmas not only leverage ancillary patents but sometimes hide or misrepresent information to the U.S. patent office in order to extend market exclusivity and high prices.
Companies Bend Patent System to Head Off Competition Long-Term: Analysis Read More »
The affiliate of the Multidisciplinary Association for Psychedelic Studies launched the fundraising effort to support its New Drug Application for an investigational, MDMA-assisted therapy for post-traumatic stress disorder.
The BioSpace team is recording from San Francisco as they bring you the the latest highlights from Day 2 at JPM2024.
As the second day of the 42nd J.P. Morgan Healthcare Conference dawned in San Francisco, experts from Boston Consulting Group, Merck, CVC and more provided their outlook on the year ahead.
AI, Neuroscience and GLP-1s Will Maintain Momentum: Expert Panel Read More »
The study could support extending acute hospital care at home, researchers said. Currently, a pandemic-era waiver for the programs is set to expire at the end of the year.
Mortality rates low for hospital-at-home patients, study finds Read More »
The J&J unit limited the use of the product in children after receiving reports of burn injuries that could be particularly harmful to them.
J&J’s Megadyne restricts use of electrodes over burn risk, triggering Class I FDA notice Read More »
“Our top priority is restoring our earnings power, full stop,” CEO Geoff Martha said Monday at the J.P. Morgan Healthcare Conference.
Medtronic focused on delivering durable revenue and profit growth Read More »
An analysis of cash on hand suggests that, despite declining operating margins, some nonprofit health systems had enough of a financial cushion to weather tough operating conditions in 2022.
The settlement is a little over half of what Walgreens was originally ordered to pay, after an arbiter said the retail pharmacy chain overcharged Humana for prescription drugs for more than a decade.
Walgreens to pay Humana $360M to settle drug pricing dispute Read More »
From the M&A outlook and tough year-over-year comparisons to emerging markets like pulsed field ablation, here are the top medical technology trends to watch this year.
